BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35063353)

  • 21. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort.
    Schlesinger S; Aleksandrova K; Pischon T; Jenab M; Fedirko V; Trepo E; Overvad K; Roswall N; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; Racine A; Kaaks R; Grote VA; Boeing H; Trichopoulou A; Pantzalis M; Kritikou M; Mattiello A; Sieri S; Sacerdote C; Palli D; Tumino R; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Quirós JR; Zamora-Ros R; Sánchez MJ; Arriola L; Ardanaz E; Tormo MJ; Nilsson P; Lindkvist B; Sund M; Rolandsson O; Khaw KT; Wareham N; Travis RC; Riboli E; Nöthlings U
    Ann Oncol; 2013 Sep; 24(9):2449-55. PubMed ID: 23720454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary malignancies of the hepato-biliary-pancreatic system in organ allograft recipients.
    Penn I
    J Hepatobiliary Pancreat Surg; 1998; 5(2):157-64. PubMed ID: 9745082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancers of the large bowel and hepatobiliary tract.
    Treat J; Woolley PV
    Cancer Chemother Biol Response Modif; 1992; 13():477-92. PubMed ID: 1327046
    [No Abstract]   [Full Text] [Related]  

  • 24. Highlights of topic "Recent advances in hepato-biliary-pancreatic science".
    Fujimoto J
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):511. PubMed ID: 26100098
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy.
    Lewis AR; Cipriano C; Wang X; Ward R; Fitzpatrick A; Scott ARM; Rashed A; Raja H; Lamarca A; Hubner RA; Valle JW; McNamara MG
    Med Oncol; 2019 Sep; 36(10):85. PubMed ID: 31493088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.
    Jia AY; Popovic A; Mohan AA; Zorzi J; Griffith P; Kim AK; Anders RA; Burkhart RA; Lafaro K; Georgiades C; Azad NS; Liddell RP; Baretti M; Kamel IR; Narang A; Yarchoan M; Meyer J
    Cancer Control; 2021; 28():10732748211009945. PubMed ID: 33882707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
    Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
    Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancers of the large bowel and hepatobiliary system.
    Treat J; Ahlgren JD; Woolley PV
    Cancer Chemother Biol Response Modif; 1987; 9():264-70. PubMed ID: 2856336
    [No Abstract]   [Full Text] [Related]  

  • 29. How Many Steps Per Day are Necessary to Prevent Postoperative Complications Following Hepato-Pancreato-Biliary Surgeries for Malignancy?
    Nakajima H; Yokoyama Y; Inoue T; Nagaya M; Mizuno Y; Kayamoto A; Nishida Y; Nagino M
    Ann Surg Oncol; 2020 May; 27(5):1387-1397. PubMed ID: 31974713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Ariake K; Unno M; Yoshida H; Kubo S; Horiguchi A; Yamaue H; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):571-580. PubMed ID: 32510820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
    Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
    Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data.
    Huschka H; Mihm S
    BMC Cancer; 2020 Nov; 20(1):1131. PubMed ID: 33228589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
    Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
    Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of HPB malignancy in the elderly.
    Pericleous M; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
    Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
    Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of hepato-pancreato-biliary emergencies in patients with cancer.
    Jajodia A; Soyer P; Barat M; Patlas MN
    Diagn Interv Imaging; 2024 Feb; 105(2):47-56. PubMed ID: 38040558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
    McNamara MG
    Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
    [No Abstract]   [Full Text] [Related]  

  • 38. Microsatellite instability in patients with hepato-biliary-pancreatic malignancies in clinical practice (KHBO 1903).
    Kubo S; Nagano H; Tsujie M; Seo S; Gotoh K; Wada H; Nakashima S; Ioka T
    Int J Clin Oncol; 2022 Aug; 27(8):1340-1347. PubMed ID: 35718824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?
    Li Y; Shen Y; Zhao R; Samudio I; Jia W; Bai X; Liang T
    Cancer Med; 2020 May; 9(9):2943-2959. PubMed ID: 32130786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
    Ramanathan RK; Belani CP; Singh DA; Tanaka M; Lenz HJ; Yen Y; Kindler HL; Iqbal S; Longmate J; Mack PC; Lurje G; Gandour-Edwards R; Dancey J; Gandara DR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):777-83. PubMed ID: 19169683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.